Developing and experimental validating a B cell exhaustion-related gene signature to assess prognosis and immunotherapeutic response in bladder cancer
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- A novel role of TGFBI in macrophage polarization and macrophage-induced pancreatic cancer growth and therapeutic resistanceCancer Letters, 2023
- Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric CancerAdvanced Science, 2023
- Tertiary Lymphoid Structures Are Associated with a Favorable Prognosis in High-Grade Serous Ovarian Cancer PatientsReproductive Sciences, 2023
- Identification and validation of a pyroptosis-related prognostic model for colorectal cancerFunctional & Integrative Genomics, 2022
- Low TINAGL1 expression is a marker for poor prognosis in breast cancerJournal of Cancer Research and Clinical Oncology, 2022
- Quantitative proteomics identifies TUBB6 as a biomarker of muscle‐invasion and poor prognosis in bladder cancerInternational Journal of Cancer, 2022
- Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAsFunctional & Integrative Genomics, 2022
- B cells and cancerCancer Cell, 2021
- Bladder CancerJAMA, 2020
- Development of an IFNγ response‐related signature for predicting the survival of cutaneous melanomaCancer Medicine, 2020